Prodrug
Top View
- EVIDENCE-BASED MEDICINE (EBM) Overview: Notes on Validity, Precision & Contextualization of Results1,2,3,4,5
- SYNTHESIS and STABILITY STUDIES of PRODRUGS and CODRUGS of NALTREXONE and 6-Β-NALTREXOL Joshua A
- Developing a Vaccine Against Multiple Psychoactive Targets: a Case Study of Heroin
- In Vitro Characterization of New Psychoactive Substances at The
- Antitussives and Substance Abuse
- Interpretation and Death Certificate
- Preventing Drug Use Among Children and Adolescents. a Research-Based Guide for Parents, Educators, and Community
- Promoieties Used in Prodrug Design: a Review
- Basic Concepts and Application of Prodrug Design
- Clinical Pharmacological Aspects of Heroin and Fentanyl Overdoses
- THE BASICS of ARV DRUG INTERACTIONS Speaker: Christopher Nguyen, Pharmd, AAHIVP
- Treatment of Stimulant Use Disorders: Current Practices and Promising Perspectives
- Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
- XP13512, a Novel Gabapentin Prodrug: 1
- A New Classification of Prodrugs: Regulatory Perspectives
- Prodrug Strategy in Drug Development Kelemen Hajnal1, Hancu Gabriel1*, Rusu Aura1, Varga Erzsébet2, Székely Szentmiklósi Blanka1
- FDA Approved Gabapentin Prodrug for Treating RLS
- NOTE Synthesis and Anticonvulsant Activity of Prodrug of Gabapentin